These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9661000)

  • 1. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M; Naber KG; Kinzig-Schippers M; Sörgel F
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin.
    Naber KG; Theuretzbacher U; Moneva-Koucheva G; Stass H
    Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.
    Straubinger M; Blenk H; Naber KG; Wagenlehner FM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3309-15. PubMed ID: 26976871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
    Naber CK; Hammer M; Kinzig-Schippers M; Sauber C; Sörgel F; Bygate EA; Fairless AJ; Machka K; Naber KG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3524-30. PubMed ID: 11709334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of fleroxacin compared with three other quinolones.
    Bremner DA; Dickie AS; Singh KP
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.
    Wagenlehner FM; Münch F; Pilatz A; Bärmann B; Weidner W; Wagenlehner CM; Straubinger M; Blenk H; Pfister W; Kresken M; Naber KG
    Antimicrob Agents Chemother; 2014; 58(2):713-21. PubMed ID: 24217699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption.
    Loose M; Naber KG; Shields P; Reinhart H; Wagenlehner FME
    Int J Antimicrob Agents; 2018 Mar; 51(3):422-426. PubMed ID: 29158143
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Wenzler E; Meyer KM; Bleasdale SC; Sikka M; Mendes RE; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
    Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.
    Aguilar L; Balcabao IP; Salvá P; Martín M; Costa J; Prieto J; Dal-ré R
    Antimicrob Agents Chemother; 1996 Jan; 40(1):17-21. PubMed ID: 8787872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].
    Guibert J; Kitzis MD; Brumpt I; Acar JF
    Pathol Biol (Paris); 1989 May; 37(5):406-10. PubMed ID: 2506514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
    García-Calvo G; Parra A; Aguilar L; Ponte C; Giménez MJ; Carcas A; Kinzig-Schippers M; Soriano F
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.